« FDA Initiative Helps Expedite Development of Seasonal and Pandemic Flu | Main | Drug-patch safety triggers an FDA probe (Philly.com) In July, the »

Teva Receives Tentative FDA Approval for Additional Strength of Generic


Teva Receives Tentative FDA Approval for Additional Strength of Generic Topamax (Money Sense)
Teva Pharmaceutical Industries Ltd. said Monday that the Food and Drug Administration gave tentative approval for another strength of a generic version of Topamax, an anti-convulsant made by Johnson & Johnson unit Ortho McNeil.
 

©2006 FDA-News.com. All rights reserved.